Company Search:
Advanced Search
Sponsored Links
X4 Pharmaceuticals Inc Company Snapshot
X4 Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares X4 Pharmaceuticals Inc with three other companies in this sector in the United States: Starpharma Holdings Limited (2018 sales of $3.83 million of which 100% was Dendritic), Aytu Bioscience Inc ($3.66 million of which 93% was Aytu), and Revance Therapeutics Inc ($3.73 million of which 100% was Botulinum Toxin Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
X4 Pharmaceuticals Inc
  Stock Performance Chart for X4 Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 10.70
(Figures in U.S. Dollars)
1 Week 0.7%   13 Weeks -20.4%  
4 Weeks -20.4%   52 Weeks -48.9%  
X4 Pharmaceuticals Inc Key Data:
  Ticker: XFOR Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 3,500,000
(Year Ending Jan 2019).
Employees: 15
  Currency: U.S. Dollars Market Cap: 133,067,394
  Fiscal Yr Ends: December Shares Outstanding: 12,436,205
  Share Type: Common Closely Held Shares: 346,846
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.